Sign up to save your podcasts
Or
Share Nidhi Bouri, Deputy Assistant Administrator, USAID Bureau for Global Health: on mpox, anti-microbial resistance, Marburg virus in Rwanda, and money headaches
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Nidhi Bouri, Deputy Assistant Administrator, USAID Bureau for Global Health: on mpox, anti-microbial resistance, Marburg virus in Rwanda, and money headaches
Nidhi Bouri, DAA at USAID Bureau for Global Health, joined us to speak to the U.S. response to the dangerous mpox outbreak (clade 1b) centered in the Democratic Republic of Congo, boosted by President Biden’s commitment at UNGA to $500m in support, including 1 million vaccine doses. Much better data is urgently needed on the needs for diagnostics and vaccines. Tensions remain high among Africa CDC, WHO, and other key institutions with proven response capability, most notably Gavi, UNICEF and the Global Fund. Much is not known about modes of transmission, and the durability and efficacy of the Jynneos vaccine for clade 1b. As the virus inevitably lands in the United States, communications will be critical. Some important progress was seen in the High Level Meeting on anti-microbial resistance. The Marburg outbreak in Rwanda is of acute concern for multiple reasons: no vaccine, little testing, little knowledge of the pattern of spread. It is crunch time, as multiple replenishments converge. “Let’s be clear, there is not enough money.”
View all episodes
4.4
5454 ratings
Nidhi Bouri, DAA at USAID Bureau for Global Health, joined us to speak to the U.S. response to the dangerous mpox outbreak (clade 1b) centered in the Democratic Republic of Congo, boosted by President Biden’s commitment at UNGA to $500m in support, including 1 million vaccine doses. Much better data is urgently needed on the needs for diagnostics and vaccines. Tensions remain high among Africa CDC, WHO, and other key institutions with proven response capability, most notably Gavi, UNICEF and the Global Fund. Much is not known about modes of transmission, and the durability and efficacy of the Jynneos vaccine for clade 1b. As the virus inevitably lands in the United States, communications will be critical. Some important progress was seen in the High Level Meeting on anti-microbial resistance. The Marburg outbreak in Rwanda is of acute concern for multiple reasons: no vaccine, little testing, little knowledge of the pattern of spread. It is crunch time, as multiple replenishments converge. “Let’s be clear, there is not enough money.”
More shows like Take as Directed
View all
PBS News Hour - Brooks and Capehart
1,222 Listeners
On Point | Podcast
3,902 Listeners
Political Gabfest
8,506 Listeners
The Truth of the Matter
282 Listeners
The Political Scene | The New Yorker
3,954 Listeners
The Lawfare Podcast
6,293 Listeners
The New Yorker Radio Hour
6,691 Listeners
The Conversation with Dasha Burns
1,531 Listeners
Russian Roulette
139 Listeners
This Does Not Compute
2 Listeners
The President’s Inbox
703 Listeners
Power Map
28 Listeners
Radio Atlantic
2,327 Listeners
The Trade Guys
147 Listeners
The Impossible State
86 Listeners
AIDS' Existential Moment
6 Listeners
Babel: Translating the Middle East
90 Listeners
Why It Matters
876 Listeners
Defense 2020
17 Listeners
Public Health On Call
618 Listeners
Theories of Change
1 Listeners
The Engine Room of Democracy
13 Listeners
Pekingology
130 Listeners
Inside Cyber Diplomacy
6 Listeners
Pandemic Planet
2 Listeners
The Ezra Klein Show
15,335 Listeners
49
25 Listeners
Intersections: Where Human Rights and Democracy Meet
4 Listeners
Industrynama
2 Listeners
Audio Briefs
7 Listeners
GeoTech Wars
5 Listeners
Driving Impact
5 Listeners
The AI Policy Podcast
33 Listeners